NewsMovies & TV
The HPV Vaccine Myths That Keep a Cancer-Preventing Shot Underused
Decades of data show the HPV vaccine safely prevents several cancers, yet myths about safety, promiscuity, and necessity still slow uptake. Here's what the evidence actually says.
Original commentary from the Cancer Explained editorial team.
Please note: this page is educational only — it is not medical advice, and it does not speculate about anyone’s health beyond reliable public reporting. For questions about your own health, talk with your healthcare team.
Few vaccines have a clearer, more direct line to cancer prevention than the HPV vaccine. Few have also generated as much lasting misinformation, given how strong the evidence for them actually is. Human papillomavirus (HPV) is a common virus. Certain high-risk strains cause most cervical cancers, plus a real share of anal, oropharyngeal (throat), penile, vulvar, and vaginal cancers. The vaccine was first approved in the mid-2000s. It's now more than two decades into real-world use. It protects against the HPV types behind most of these cancers. Yet uptake in the U.S. still lags behind other rich countries. Public health researchers point to a handful of recurring myths as a major reason why.
What's medically accurate
The vaccine's safety record is one of the most studied of any recommended vaccine. Over 20-plus years and hundreds of millions of doses worldwide, monitoring has found brief soreness and mild reactions at the injection site. That's comparable to other routine vaccines. There's no confirmed link to serious long-term harm. Effectiveness data is just as strong. Clinical trials and real-world tracking show high success at preventing infection with the targeted HPV types. Protection has lasted more than a decade so far in ongoing studies. Public health models estimate that widespread vaccination could cut cervical cancer cases by as much as 90% in vaccinated groups. That's because HPV types 16 and 18 alone cause roughly 70% of cervical cancer cases.
The vaccine works best when given before a person's first exposure to HPV. That's why it's recommended starting around ages 11-12, well before most people become sexually active. It still helps, though somewhat less, when given later — through the mid-20s and in some cases beyond.
What the myths get wrong
Several myths come up often enough to name directly. First, the vaccine does not lead to earlier or more sexual activity. Many large studies comparing vaccinated and unvaccinated teens have found no difference in sexual behavior. Second, the vaccine is not unsafe for future fertility. No solid evidence links it to infertility. Anyone currently pregnant can simply delay it until after pregnancy, out of general caution rather than known risk. Third, some people think the vaccine is pointless if they're already sexually active or have met some HPV strains. But the vaccine covers several HPV types. It can still protect against strains a person hasn't met yet. Fourth, getting vaccinated does not remove the need for cervical cancer screening. The vaccine doesn't cover every cancer-causing HPV type. So vaccinated people still need the same Pap and HPV test schedule.
Signs and symptoms
HPV infection itself usually causes no symptoms. That's part of why it spreads so easily, and why vaccination and screening — not watching for symptoms — are the main tools against it. When HPV-related cancers do cause symptoms, they vary by site. Cervical cancer can cause abnormal bleeding or discharge. Oropharyngeal cancer can cause a lasting sore throat, trouble swallowing, or a lump in the neck. Anal and genital-area cancers can cause pain, bleeding, or visible sores. All of these symptoms have far more common, non-cancer explanations. So having one is a reason to get checked, not a reason to assume cancer.
Prevention and screening
Vaccination and screening work as a team, not as substitutes for each other. The HPV vaccine is recommended for preteens, ideally before any HPV exposure. It's approved for use up to age 45 in some cases, with a doctor's input. Cervical cancer screening — Pap tests, HPV tests, or both, depending on age — should continue on schedule for vaccinated and unvaccinated people alike. That's because screening catches early cell changes from any high-risk HPV type, whether the vaccine covers it or not.
Supporting real cancer information
Misinformation about a genuinely cancer-preventing vaccine has real costs. Lower vaccination rates mean preventable cancers that otherwise would not happen. Groups like the National Cancer Information Foundation work to counter that misinformation with free, medically grounded information. That way, families can decide on vaccination based on evidence, not rumor.
How this article was prepared
An AI-assisted editorial system helped prepare this page. No named medical reviewer has reviewed it unless one is listed.
Cancer Explained is published by the National Cancer Information Foundation. It is not medical advice and does not suggest a test or treatment.
See an error, old source, or unclear wording? Tell us.
Know someone who needs this?
Plenty of people are looking for something like this and do not know where to start. If this would help a friend or someone you love, send it on — we have written an opening line so you do not have to stare at an empty message. You can change every word of it.
Your message is written and sent in your own email or messaging app — we never see who you send it to, and nothing is added to any list.
Put the story in context
Prevention, possible warning signs, screening, and diagnosis
This story relates to cervical-cancer. The information below is general: it does not reveal anything else about a public person’s health, and not every point applies to every cancer. Personal advice depends on age, symptoms, family history, exposures, and medical history.
Prevention and risk reduction
Not every cancer can be prevented. Avoiding tobacco, protecting skin from ultraviolet radiation, limiting alcohol, staying active, and receiving recommended HPV or hepatitis B vaccination can lower the risk of certain cancers. A risk factor is not a prediction or a cause in one individual.
Symptoms and possible early signs
Possible signs vary and are often caused by conditions other than cancer. Changes worth discussing include a new lump, unexplained bleeding or weight loss, a persistent cough, lasting bowel or bladder changes, a changing skin spot, or symptoms that persist or worsen. Some early cancers cause no symptoms.
Screening and early detection
Screening looks for certain cancers before symptoms begin. Recommended tests exist only for some cancers and depend on age and risk. Screening can have benefits and harms; it is not the same as evaluating a new symptom, and there is no single routine scan or blood test that reliably screens for every cancer.
How cancer is diagnosed
Diagnosis may involve a history and exam, imaging, laboratory tests, and often a biopsy. Pathology can identify the cancer type and may test biomarkers that guide treatment. Symptoms, screening results, tumor markers, or online stories alone cannot confirm cancer.
Learn about this story’s cancer topic
A public story may encourage questions, but it should not be used to estimate your risk or choose testing. Contact a healthcare professional about a persistent or concerning change. Seek urgent care for severe or rapidly worsening symptoms.